Multidisciplinary Evaluation of Elderly Patients With Digestive Cancer (EPODIG-G)

Launched by INSTITUT DE CANCÉROLOGIE STRASBOURG EUROPE · Oct 1, 2021

Keywords

ClinConnect Summary

The EPODIG-G clinical trial is studying how different treatments affect elderly patients with digestive cancers, such as stomach or colon cancer, who are starting chemotherapy or targeted therapy. This trial is taking place at the Strasbourg Europe Cancerology Institute in France and aims to see how these patients respond to the treatments and what their overall health looks like during the process.

To be eligible for the trial, participants must be at least 75 years old and have a diagnosis of digestive cancer that requires treatment. They can also have had previous chemotherapy. Participants need to be able to communicate in French and should expect to sign a consent form agreeing to join the study. The trial is currently recruiting patients, and anyone interested should consider whether they meet the criteria and discuss it with their healthcare provider. This study is important because it focuses on the unique needs of elderly patients, helping to improve their care and treatment outcomes.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients must be ≥ 75 years old
• • Performance status 0, 1 or 2
• • Diagnostic of digestive cancer, all stages (adjuvant or metastatic), with an indication for chemotherapy treatment or targeted therapy
• • Patients previously treated with one or several lines of chemotherapy for this digestive cancer are eligible
• • Estimated life expectancy ≥ 3 months
• • Patients able to speak, read and understand French
• • Signed informed consent from the patient
• • Patients must have a social security coverage
• Exclusion Criteria:
• • History of differentiated neuroendocrine tumors grade 1 or 2 (pancreas, small intestine)
• • History of another treated cancer during the last five years
• • History of major surgery and/or curative radiation therapy during the last 4 weeks before inclusion
• • Patients unable to submit to medical follow-up for geographical, social or psychological reasons
• • Patients placed under guardianship